Live Breaking News & Updates on Ovarian Cancer Risk Test

Stay updated with breaking news from Ovarian cancer risk test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genetic Technologies launches US$2 million share offering to fund expansion and innovation

Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) is targeting gross proceeds of around US$2 million from a share offering announced today,. ....

Genetic Technologies Limited , Genetype Multi Risk , Southeast Asia , Comprehensive Hereditary Breast , Ovarian Cancer Risk Test , Depositary Shares , Genetic Technologies , Extraordinary General Meeting ,

Genetic Technologies (GENE) Announces $2 Million Registered Direct Offering

Genetic Technologies (GENE) Announces $2 Million Registered Direct Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Hc Wainwright Co , Genetic Technologies Limited , Exchange Commission , Depositary Shares , Genetype Multi Risk , South East Asia , World First Comprehensive Hereditary Breast , Ovarian Cancer Risk Test , Securities Act ,

Genetic Technologies Announces $2 Million Registered Direct Offering

MELBOURNE, Australia, April 19, 2024 Genetic Technologies Limited , a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announced that it has. ....

United States , New York , Simon Morriss , Hc Wainwright Co , Genetic Technologies Limited , Exchange Commission , Genetic Technologies , Technologies Limited , Depositary Shares , Genetype Multi Risk , South East Asia , World First Comprehensive Hereditary Breast , Ovarian Cancer Risk Test , Securities Act ,

Genetic Technologies Announces $2 Million Registered Direct Offering

18.04.2024 - MELBOURNE, Australia, April 19, 2024 (GLOBE NEWSWIRE) - Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, Company , GTG , or Genetic Technologies ), a global leader in guideline-driven genomics-based tests in health, wellness and serious . Seite 1 ....

New York , United States , Hc Wainwright Co , Exchange Commission , Genetype Multi Risk , South East Asia , World First Comprehensive Hereditary Breast , Ovarian Cancer Risk Test ,

Annual Results – Momentum Building on our Commercial Plans

MELBOURNE, Australia, Aug. 30, 2023 Genetic Technologies Limited , a global leader in guideline driven genomics-based tests in health, wellness and serious disease is pleased to report annual. ....

Carolyn Young , Joel Evans , William Stanford , Elisa Larkin , Adrian Mulcahy , Precision Medicine Centers Of Excellence , Exchange Commission , Genetype Group , Automic Group , Genetic Technologies Limited , Precision Medicine Centers , Centre Of Excellence , Test Panel , Genetic Technologies , Pioneering Research , Technologies Limited , Comprehensive Breast , Ovarian Cancer Risk Test , Clinical Impact , Type Multi Test Panel , Medical Leadership , Key Opinion Leaders , Polygenic Risk Scores ,